Biology of Blood and Marrow Transplantation
Volume 14, Issue 2 , Pages 229-235 , February 2008

Cardiac Chamber Hypertrophy following Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency

  • Sean R. Bulley

      Affiliations

    • Division of Immunology/Allergy, Blood and Marrow Transplant Unit, Department of Paediatrics, The Hospital for Sick Children and the University of Toronto, Toronto, Canada
    • ,
  • Lee Benson

      Affiliations

    • Division of Cardiology, Cardiac Diagnostic and Interventional Unit, Cardiology Department, The Hospital for Sick Children and the University of Toronto, Toronto, Canada
    • ,
  • Eyal Grunebaum

      Affiliations

    • Division of Immunology/Allergy, Blood and Marrow Transplant Unit, Department of Paediatrics, The Hospital for Sick Children and the University of Toronto, Toronto, Canada
    • ,
  • Chaim M. Roifman

      Affiliations

    • Division of Immunology/Allergy, Blood and Marrow Transplant Unit, Department of Paediatrics, The Hospital for Sick Children and the University of Toronto, Toronto, Canada
    • Corresponding Author InformationCorrespondence and reprint requests: Chaim M. Roifman, MD, FRCPC, Division of Immunology & Allergy, Paediatrics & Immunology, The Hospital for Sick Children, 555 University Avenue, 7th Floor, Elm Wing, Room 7277, Toronto, Ontario M5G 1X8.

Received 26 April 2007 ,Accepted 31 October 2007.

References 

  1. Grunebaum E, Mazzolari E, Porta F, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA. 2006;295:508–518
  2. Van Lint MT, Uderzo C, Locasciulli A, et al. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. Blood. 1998;92:2288–2293
  3. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308–1320
  4. Israel BA, Sherman FS, Guthrie RD. Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants. Am J Perinatol. 1993;10:307–310
  5. Bobele GB, Ward KE, Bodensteiner JB. Hypertrophic cardiomyopathy during corticotropin therapy for infantile spasms. A clinical and echocardiographic study. Am J Dis Child. 1993;147:223–225
  6. Bullington N, Kartel J, Khoury P, Mitsnefes M. Left ventricular hypertrophy in pediatric kidney transplant recipients: long-term follow-up study. Pediatr Transplant. 2006;10:811–815
  7. Hori T, Suzuki N, Mizue N, Hatakeyama N, Takamuro M, Tsutsumi H. Relapse of T-cell ALL after stem cell transplant presenting as hypertrophic cardiomyopathy: the value of non-invasive diagnostic imaging in detecting cardiac leukemia. Pediatr Blood Cancer. 2006;46:108–111
  8. Vinallonga X, Sanz N, Balaguer A, Miro L, Ortega JJ, Casaldaliga J. Hypertrophic cardiomyopathy in mucopolysaccharidoses: regression after bone marrow transplantation. Pediatr Cardiol. 1992;13:107–109
  9. Lesnik JJ, Singh GK, Balfour IC, Wall DA. Steroid-induced hypertrophic cardiomyopathy following stem cell transplantation in a neonate: a case report. Bone Marrow Transplant. 2001;27:1105–1108
  10. Lee KJ, McCrindle BW, Bohn DJ, et al. Clinical outcomes of acute myocarditis in childhood. Heart. 1999;82:226–233
  11. Heyderman RS, Morgan G, Levinsky RJ, Strobel S. Successful bone marrow transplantation and treatment of BCG infection in 2 patients with severe combined immunodeficiency. Eur J Pediatr. 199;150:477-480.
  12. Murdych T, Weisdorf DJ. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant. 2001;28:283–287
  13. Kamezaki K, Fukuda T, Makino S, Harada M. Cyclophosphamide-induced cardiomyopathy in a patient with seminoma and a history of mediastinal irradiation. Intern Med. 2005;44:120–123
  14. Rackley C, Schultz KR, Goldman FD, et al. Cardiac manifestations of graft-versus-host disease. Biol Blood Marrow Transplant. 2005;11:773–780
  15. Pokorny JJ, Roth F, Balfour I, Rinehart G. An unusual complication of the treatment of a hemangioma. Ann Plast Surg. 2002;48:83–87
  16. Alpert BS. Steroid-induced hypertrophic cardiomyopathy in an infant. Pediatr Cardiol. 1984;5:117–118
  17. Whitehurst RM, Zhang M, Bhattacharjee A, Li M. Dexamethasone-induced hypertrophy in rat neonatal cardiac myocytes involves an elevated L-type Ca(2+)current. J Mol Cell Cardiol. 1999;31:1551–1558
  18. Muller O, Pradervand S, Berger S, et al. Identification of corticosteroid-regulated genes in cardiomyocytes by serial analysis of gene expression. Genomics. 2007;89:370–377
  19. Palmer BM, Chen Z, Lachapelle RR, Hendley ED, LeWinter MM. Cardiomyocyte function associated with hyperactivity and/or hypertension in genetic models of LV hypertrophy. Am J Physiol Heart Circ Physiol. 2006;290:463–473
  20. Shapiro LM, Beevers DG. Malignant hypertension: cardiac structure and function at presentation and during therapy. Br Heart J. 1983;49:477–484
  21. Lister K, Autelitano DJ, Jenkins A, Hannan RD, Sheppard KE. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1. Cardiovasc Res. 2006;70:555–565
  22. Roberts CA, Stern DL, Radio SJ. Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. Transplantation. 2002;74:817–821
  23. Wilkins BJ, Dai YS, Bueno OF, et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res. 2004;94:110–118
  24. Gratwohl A, Brand R, Frassoni F, et al. Acute and chronic leukemia working parties; cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant. 2005;36:757–769

PII: S1083-8791(07)00556-3

doi: 10.1016/j.bbmt.2007.10.027

Biology of Blood and Marrow Transplantation
Volume 14, Issue 2 , Pages 229-235 , February 2008

Article Tools

* Image Usage & Resolution